Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Bridgewater

Showing results (11-20 of 124) with videos related to

Pageof 13
Sort By:
BMC Cancer|August 22, 2014
A VELOUR post hoc subset analysis: prognostic groups and treatment outcomes in patients with metastatic colorectal cancer treated with aflibercept and FOLFIRIIan Chau, Florence Joulain, Sheikh Usman Iqbal, et al.
Cancer Treatment Reviews|March 18, 2021
Targeting FGFR inhibition in cholangiocarcinomaLipika Goyal, Sarinya Kongpetch, Valerie E Crolley, et al.
Lancet (London, England)|June 28, 2002
Is the NICE process flawed?Jim Cassidy, John Bridgewater, Paul Mainwaring, et al.
Therapeutic Advances in Medical Oncology|April 3, 2023
Adjuvant therapy of biliary tract cancersJoanna Kefas, John Bridgewater, Arndt Vogel, et al.
Oncology and Therapy|October 8, 2025
Opportunities and Approaches to Optimising Advanced Cholangiocarcinoma Outcomes in the Era of Targeted Therapies: A Narrative ReviewTeresa Macarulla, Cindy Neuzillet, Gerald W Prager, et al.
European Journal of Cancer (Oxford, England : 1990)|June 13, 2015
Cisplatin and gemcitabine in patients with advanced biliary tract cancer (ABC) and persistent jaundice despite optimal stenting: Effective intervention in patients with luminal diseaseAngela Lamarca, Sarah Benafif, Paul Ross, et al.
Journal of Hepatology|January 20, 2020
Systemic therapies for intrahepatic cholangiocarcinomaRobin Kate Kelley, John Bridgewater, Gregory J Gores, et al.
British Journal of Hospital Medicine (London, England : 2005)|January 14, 2012
Use of bevacizumab in the treatment of metastatic colorectal cancerSherif Raouf, John Bridgewater, Richard Ellis, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 27, 2004
Efficient retroviral vector targeting of carcinoembryonic antigen-positive tumorsSimon Chowdhury, Kerry A Chester, John Bridgewater, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 13, 2017
The prognostic value of derived neutrophil to lymphocyte ratio in oesophageal cancer treated with definitive chemoradiotherapySamantha Cox, Christopher Hurt, Tal Grenader, et al.
Pageof 13

Showing results (11-20 of 124) with videos related to

Sort By:
Pageof 13
BMC Cancer|August 22, 2014
A VELOUR post hoc subset analysis: prognostic groups and treatment outcomes in patients with metastatic colorectal cancer treated with aflibercept and FOLFIRIIan Chau, Florence Joulain, Sheikh Usman Iqbal, et al.
Cancer Treatment Reviews|March 18, 2021
Targeting FGFR inhibition in cholangiocarcinomaLipika Goyal, Sarinya Kongpetch, Valerie E Crolley, et al.
Lancet (London, England)|June 28, 2002
Is the NICE process flawed?Jim Cassidy, John Bridgewater, Paul Mainwaring, et al.
Therapeutic Advances in Medical Oncology|April 3, 2023
Adjuvant therapy of biliary tract cancersJoanna Kefas, John Bridgewater, Arndt Vogel, et al.
Oncology and Therapy|October 8, 2025
Opportunities and Approaches to Optimising Advanced Cholangiocarcinoma Outcomes in the Era of Targeted Therapies: A Narrative ReviewTeresa Macarulla, Cindy Neuzillet, Gerald W Prager, et al.
European Journal of Cancer (Oxford, England : 1990)|June 13, 2015
Cisplatin and gemcitabine in patients with advanced biliary tract cancer (ABC) and persistent jaundice despite optimal stenting: Effective intervention in patients with luminal diseaseAngela Lamarca, Sarah Benafif, Paul Ross, et al.
Journal of Hepatology|January 20, 2020
Systemic therapies for intrahepatic cholangiocarcinomaRobin Kate Kelley, John Bridgewater, Gregory J Gores, et al.
British Journal of Hospital Medicine (London, England : 2005)|January 14, 2012
Use of bevacizumab in the treatment of metastatic colorectal cancerSherif Raouf, John Bridgewater, Richard Ellis, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 27, 2004
Efficient retroviral vector targeting of carcinoembryonic antigen-positive tumorsSimon Chowdhury, Kerry A Chester, John Bridgewater, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 13, 2017
The prognostic value of derived neutrophil to lymphocyte ratio in oesophageal cancer treated with definitive chemoradiotherapySamantha Cox, Christopher Hurt, Tal Grenader, et al.
Pageof 13